✦ LIBER ✦

HER2-Positive Early Breast Cancer and Trastuzumab: A Surgeon’s Perspective

✍ Scribed by Swati Kulkarni; David G. Hicks

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

HER2-positive breast cancer: trastuzumab

✍ Roger Y. Tsang; Richard S. Finn 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 176 KB

An Economic Evaluation of Adjuvant Trast

✍ Wen Chen; Zefei Jiang; Zhimin Shao; Qiang Sun; Kunwei Shen 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Nine-week trastuzumab treatment versus 5

✍ Onder Tonyali, Ugur Coskun, Nur Sener, Mevlude Inanc, Tulay Akman, Berna Oksuzog 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 240 KB

Paclitaxel, carboplatin, and trastuzumab

✍ Andrew D. Seidman; Larry Norton 📂 Article 📅 2005 🏛 Current Science Inc. 🌐 English ⚖ 136 KB

Trastuzumab after primary treatment for

✍ Rebecca Dent; Mark Clemons 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 80 KB

Beyond trastuzumab: New treatment option

✍ Kamal S. Saini; Hatem A. Azim Jr; Otto Metzger-Filho; Sherene Loi; Christos Soti 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 255 KB